Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2024

Feb 16, 2024

33003_dirs_2024-02-16_838b7186-7439-40d7-a38d-3c326fa849e9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-02-13

Reporting Person: Ganot Ilan (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-13 Restricted Stock Units $ A 19444 Acquired Common Stock (19444) Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F2: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.